Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and CyberKnife M6 Systems to expand access to advanced, life-saving technology for more cancer patients. The next-generation systems will replace existing Accuray devices as well as competitive conventional linear accelerators. The order was entered into backlog during the company's fourth fiscal quarter which ends June 30, 2018.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now